Oxygen Desaturation During Hemodialysis
|ClinicalTrials.gov Identifier: NCT02501044|
Recruitment Status : Completed
First Posted : July 17, 2015
Last Update Posted : July 17, 2015
Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues.
The investigators hypothesize that:
- The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients.
- There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.
|Condition or disease|
|Renal Disease Hypoxia|
|Study Type :||Observational|
|Actual Enrollment :||5500 participants|
|Official Title:||Oxygen Desaturation During Hemodialysis: Clinical Correlates and Association With Adverse Outcomes|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||January 2015|
|Actual Study Completion Date :||January 2015|
- Cumulative number of deoxygenation episodes [ Time Frame: Up to 36 months ]Crit-Line III monitor recordings (which contain oxygen saturation data) will be extracted from the RRI database and the cumulative number of deoxygenation episodes will be analyzed.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02501044
|United States, New York|
|Renal Research Institute|
|New York, New York, United States, 10065|
|Principal Investigator:||Peter Kotanko, MD||Renal Research Institute|